BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Kidney
,
Nosology
,
Vitamin E
,
rs7903146
,
PTEN
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dopamine agonists
(compound)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
CTSH
FTH1
DRD2
SLC7A11
CCL2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cell periphery
organic cyclic compound binding
response to organic substance
organic cyclic compound metabolic process
vesicle
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Genomics Assisted Toxicity Evaluation system study - Rat Liver Single Dose
Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
Genomics Assisted Toxicity Evaluation system study - Rat Hepatocytes
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Lutein granulosa cells of polycystic ovarian syndrome subjects treated with cabergoline
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.
Efficacy and safety of dopamine agonists in restless legs syndrome.
Dopamine agonist use and the risk of heart failure.
Etiology of OHSS and use of dopamine agonists.
Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Switching From Oral Dopamine Agonists to Rotigotine
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects Wi…
The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dop…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ